Skip to main content
. 2021 Oct 23;12(12):3079–3092. doi: 10.1007/s13300-021-01166-z

Fig. 1.

Fig. 1

Cost-effectiveness acceptability curves under different scenarios. T1D type 1 diabetes, T2D type 2 diabetes, RCT randomized clinical trial, RWE real-world evidence